Asensus Surgical (FRA:2TX) Total Liabilities : €46.29 Mil (As of Jun. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Asensus Surgical Total Liabilities?

Asensus Surgical's Total Liabilities for the quarter that ended in Jun. 2024 was €46.29 Mil.

Asensus Surgical's quarterly Total Liabilities increased from Dec. 2023 (€23.54 Mil) to Mar. 2024 (€25.57 Mil) and increased from Mar. 2024 (€25.57 Mil) to Jun. 2024 (€46.29 Mil).

Asensus Surgical's annual Total Liabilities increased from Dec. 2021 (€15.25 Mil) to Dec. 2022 (€15.49 Mil) and increased from Dec. 2022 (€15.49 Mil) to Dec. 2023 (€23.54 Mil).

Asensus Surgical Total Liabilities Historical Data

The historical data trend for Asensus Surgical's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Asensus Surgical Total Liabilities Chart

Asensus Surgical Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

17.32

13.72

15.25

15.49

23.54

Asensus Surgical Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Total Liabilities	Get a 7-Day Free Trial															15.57	22.00	23.54	25.57	46.29

Asensus Surgical Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Asensus Surgical's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	11.58	+	(4.26	+	7.435
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0.266	+	0	+	0)
	=	23.54

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	54.182	-	30.641
	=	23.54

Asensus Surgical's Total Liabilities for the quarter that ended in Jun. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	37.086	+	(3.766	+	5.199
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0.24	+	0	+	0)
	=	46.29

Total Liabilities	=	Total Assets (Q: Jun. 2024 )	-	Total Equity (Q: Jun. 2024 )
	=	35.768	-	-10.523
	=	46.29

Asensus Surgical Total Liabilities Related Terms

Thank you for viewing the detailed overview of Asensus Surgical's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Asensus Surgical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Asensus Surgical Inc (FRA:2TX) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

1 TW Alexander Drive, Suite 160, Durham, NC, USA, 27703

Website

https://www.asensus.com

Asensus Surgical Inc is a medical device company that digitizes the interface between the surgeon and the patient to improve minimally invasive surgery through digital laparoscopy. It enables the use of capabilities such as augmented intelligence, connectivity, and robotics in laparoscopy and seeks to address the current clinical, cognitive, and economic shortcomings in surgery. The Senhance Surgical System is the first machine vision system for use in robotic surgery, which is powered by the new Intelligent Surgical Unit that enables augmented intelligence in surgery and brings the benefits of digital laparoscopy to patients around the world. The company's single segment includes the research, development, and sale of medical device robotics to improve minimally invasive surgery.

Asensus Surgical Headlines

No Headlines